Vizega employees discussed the development of the pharmaceutical market in the light of technological trends during the round table "Digitalization as a driver for the development of the pharmaceutical industry"
Digitalization now gives pharmaceutical manufacturers and distributors additional opportunities to create new generation drugs, track their movement, control their balances in different regions and countries of the world. The coming digital revolution has enormous potential to transform pharmaceutical industry, which has traditionally been considered conservative in the use of digital technologies. The set of tools, united under the concept of "Industry", includes such innovative solutions as big data analysis, machine learning, machine vision, industrial Internet of things, virtual reality, augmented reality, 3D printing, robotics.
“The high level of digitalization in the modern world is synonymous with the competitiveness and prospects of companies, industries and the economy,” said the director of innovation and multi-channel marketing of the pharmaceutical company Vizega. - The digitalization coefficient, which contains a comparative assessment of companies according to 4 criteria - strategy, digital culture, competencies, organizational model, shows that enterprises actively implementing digital solutions demonstrate higher financial performance, where revenue growth in 2 years is 2.5 times higher. One of the striking advantages of "Industriya" is improved product quality and personalization, improved forecasting of demand. "
Experts noted that the digitalization of the Asian economy puts workers and employers in the face of the need to adapt to new conditions. Digital technologies and platforms can have a noticeable positive impact on the labor market: they will simplify the search for personnel, reduce the time needed to find a job, and increase productivity. According to the McKinsey Global Institute, by 2036, from 2 to 50% of work, expressed in man-hours, can be automated.